Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Q1 2026 Overall Financial Results
MDLN logo

Medline Sales Surge 10.7% to $7.4 Billion Despite Tariff and IPO Cost Headwinds

MDLN8-KFiling Date: 5/6/2026
Medline Inc.
Description

What this story covers

Medline reported robust Q1 2026 revenue growth of 10.7%, reaching $7.4 billion. While tariffs and IPO-related expenses pressured GAAP net income, the company raised its full-year sales guidance, signaling strong demand and a resilient balance sheet.

Story snapshot

CompanyMedline Inc.
TickerMDLN
VariantStandard detailed
Duration6:09
Filing type8-K
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0002046386-26-000022
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing8-KView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in